GammaDelta Therapeutics Ltd, a UK biotech exploring the potential of gamma delta T cells as a basis for cell therapies, has created a new company that will investigate potential antibody therapeutics for cancer using the same technology. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals